Yi Zong

674 total citations
17 papers, 597 citations indexed

About

Yi Zong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yi Zong has authored 17 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Yi Zong's work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (5 papers). Yi Zong is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (5 papers). Yi Zong collaborates with scholars based in China. Yi Zong's co-authors include Di Lü, Lianmei Zhong, Jun Sun, Ying He, Yuemin Li, Ligong Bian, Qinglong Ai, Yidan Liu, Wei Zhang and Jiazhi Guo and has published in prestigious journals such as PLoS ONE, Biomedicine & Pharmacotherapy and Antioxidants.

In The Last Decade

Yi Zong

16 papers receiving 596 citations

Peers

Yi Zong
Yan Mi China
Xiaobo Sun China
Yihui Deng China
Yue Jia China
Jinsong Xue China
Haibo Zhu China
Carmen López‐Sánchez Spain
Alessio Alfieri United Kingdom
Daidi Li China
Yan Mi China
Yi Zong
Citations per year, relative to Yi Zong Yi Zong (= 1×) peers Yan Mi

Countries citing papers authored by Yi Zong

Since Specialization
Citations

This map shows the geographic impact of Yi Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zong more than expected).

Fields of papers citing papers by Yi Zong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zong. The network helps show where Yi Zong may publish in the future.

Co-authorship network of co-authors of Yi Zong

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zong. A scholar is included among the top collaborators of Yi Zong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zong. Yi Zong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Zong, Yi, et al.. (2024). Optimization of Multilayer Microwave Absorbers using Multi-strategy Improved Gold Rush Optimizer. The Applied Computational Electromagnetics Society Journal (ACES). 708–717. 1 indexed citations
3.
Zong, Yi, Xiaorui Wang, Yi Zhang, et al.. (2023). Sitagliptin Ameliorates Creb5/lncRNA ENSMUST00000213271-Mediated Vascular Endothelial Dysfunction in Obese Mice. Cardiovascular Drugs and Therapy. 38(4). 679–691. 2 indexed citations
4.
Lǚ, Kai, et al.. (2022). Hsa_circ_0001982 promotes the proliferation, invasion, and multidrug resistance of osteosarcoma cells. Journal of Clinical Laboratory Analysis. 36(7). 7 indexed citations
5.
6.
Tan, Na, Yi Zhang, Yan Zhang, et al.. (2021). Berberine ameliorates vascular dysfunction by a global modulation of lncRNA and mRNA expression profiles in hypertensive mouse aortae. PLoS ONE. 16(2). e0247621–e0247621. 7 indexed citations
7.
Zhang, Yi, Na Tan, Yi Zong, et al.. (2021). LncRNA ENSMUST00000155383 is Involved in the Improvement of DPP-4 Inhibitor MK-626 on Vascular Endothelial Function by Modulating Cacna1c-Mediated Ca2+ Influx in Hypertensive Mice. Frontiers in Molecular Biosciences. 8. 724225–724225. 5 indexed citations
8.
Chen, Can, et al.. (2021). miR-369-3p Serves as Prognostic Factor and Regulates Cancer Progression of Hepatocellular Carcinoma. Personalized Medicine. 18(4). 375–388. 3 indexed citations
9.
Sun, Tian‐Xiao, et al.. (2020). Identification of plasma microRNA-22 as a marker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma. Journal of International Medical Research. 48(12). 1220767370–1220767370. 7 indexed citations
10.
Wei, Yongpeng, et al.. (2020). LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression. Biomedicine & Pharmacotherapy. 125. 109890–109890. 29 indexed citations
11.
Tang, Tianyu, Yi Zong, Yinan Shen, et al.. (2019). Predicting surgical site infections using a novel nomogram in patients with hepatocelluar carcinoma undergoing hepatectomy. World Journal of Clinical Cases. 7(16). 2176–2188. 10 indexed citations
12.
Wang, Zhuo, Ning Yang, Haibin Zhang, et al.. (2018). MicroRNA-506 suppresses invasiveness and metastasis of human hepatocellular carcinoma cells by targeting IL8.. PubMed. 8(8). 1586–1594. 12 indexed citations
13.
14.
Zong, Yi, Lin Sun, Bin Liu, et al.. (2012). Resveratrol Inhibits LPS-Induced MAPKs Activation via Activation of the Phosphatidylinositol 3-Kinase Pathway in Murine RAW 264.7 Macrophage Cells. PLoS ONE. 7(8). e44107–e44107. 142 indexed citations
15.
Zhong, Lianmei, Yi Zong, Lin Sun, et al.. (2012). Resveratrol Inhibits Inflammatory Responses via the Mammalian Target of Rapamycin Signaling Pathway in Cultured LPS-Stimulated Microglial Cells. PLoS ONE. 7(2). e32195–e32195. 142 indexed citations
16.
Zong, Yi, Lianmei Zhong, Yuemin Li, et al.. (2011). Gastrodin Inhibits Expression of Inducible NO Synthase, Cyclooxygenase-2 and Proinflammatory Cytokines in Cultured LPS-Stimulated Microglia via MAPK Pathways. PLoS ONE. 6(7). e21891–e21891. 195 indexed citations
17.
Zhao, Jian, Xiaoguang Zhang, Rui Chen, et al.. (2011). [High-risk human papilloma virus DNA detection kit (cervista HPV HR) should be highly validated clinically in cervical cancer screening programs].. PubMed. 25(2). 149–51. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Mi Breakdown of academic impact, for papers by Xiaobo Sun Breakdown of academic impact, for papers by Yihui Deng Breakdown of academic impact, for papers by Yue Jia Breakdown of academic impact, for papers by Jinsong Xue Breakdown of academic impact, for papers by Haibo Zhu Breakdown of academic impact, for papers by Carmen López‐Sánchez Breakdown of academic impact, for papers by Alessio Alfieri Breakdown of academic impact, for papers by Daidi Li
Rankless by CCL
2026